INS and type 2 diabetes mellitus: RELA can suppress inflammation and improve insulin sensitivity, which significantly regulate type I and type II diabetes [13,14].MiR-101a can promote inflammatory cytokine-mediated beta-cell dysfunction to regulate the development and progression of type I diabetes [15].